Why is DocGo stock tumbling today?
DocGo (DCGO) shares fell 12.7% pre-open to $0.62 after its Q2 2026 adjusted loss was $0.16 per share versus $0.10 consensus. Revenue was $73.4M, below $75.4M forecast and down 8.7% YoY, tied to wind-down of migrant contracts. It widened FY2026 adjusted EBITDA loss to $17M-$22M and agreed to acquire Hicuity Health (~$65M trailing revenue).
How this was made
The 30-second read
Why it matters
Traders are repricing DCGO based on a Q2 earnings miss, a sharply widened full-year adjusted EBITDA loss range, and added uncertainty from a definitive acquisition agreement plus an SEC 10-Q filing extension request.
Market read
A same-day combination of earnings miss, materially worse guidance, and acquisition/integration and filing uncertainty is a high-conviction catalyst for DCGO’s near-term trading.
What to watch
The acquisition of Hicuity Health could offset some revenue softness if integration succeeds, and the SEC 10-Q extension may be procedural rather than signaling deeper issues.
Background
DocGo is a mobile health and medical transportation company facing contract wind-downs and ongoing profitability challenges.
Ticker impact
DocGo reported Q2 2026 adjusted loss of $0.16 vs $0.10 consensus, revenue $73.4M vs $75.4M, and widened full-year adjusted EBITDA loss guidance to $17M-$22M.
Bearish near-term as guidance deterioration and integration/filing uncertainty likely keep downside pressure until clarity on acquisition and SEC filing timing.
The article cites multiple same-day fundamentals for DCGO: Q2 miss, guidance widening more than double prior range, acquisition agreement introducing integration risk, and a requested SEC 10-Q filing extension.
Market effects
Weakens sentiment for mobile health and medical transportation providers by highlighting contract wind-down risk and profitability delays.
Primarily US micro-cap risk appetite, with broader index weakness amplifying the move.
Limited direct global spillover; the story is company-specific with macro backdrop only.
Counterpoint
Core revenue excluding migrant-related programs grew 19%, so the market may be over-penalizing one-time contract wind-down versus underlying demand.
Key entities
- public_companyDocGo
Mobile health and medical transportation provider whose Q2 results, guidance, and acquisition agreement drove the pre-market selloff.
- public_or_private_companyHicuity Health
Telemedicine provider DocGo agreed to acquire, adding integration risk at a strained balance sheet.
- regulatorSEC
DocGo requested a brief extension to file its quarterly Form 10-Q.
